| Year |
Citation |
Score |
| 2022 |
Makhlin I, McAndrew NP, Wileyto EP, Clark AS, Holmes R, Bottalico LN, Mesaros C, Blair IA, Jeschke GR, Fox KR, Domchek SM, Matro JM, Bradbury AR, Feldman MD, Hexner EO, ... Bromberg JF, et al. Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer. Npj Breast Cancer. 8: 122. PMID 36369506 DOI: 10.1038/s41523-022-00487-x |
0.328 |
|
| 2022 |
Strillacci A, Sansone P, Rajasekhar VK, Turkekul M, Boyko V, Meng F, Houck-Loomis B, Brown D, Berger MF, Hendrickson RC, Chang Q, de Stanchina E, Pareja F, Reis-Filho JS, Rajappachetty RS, ... ... Bromberg J, et al. ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance. Npj Breast Cancer. 8: 96. PMID 35999225 DOI: 10.1038/s41523-022-00470-6 |
0.334 |
|
| 2020 |
Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S, Mark MT, Steiner L, Benito-Martin A, Lucotti S, Di Giannatale A, ... ... Bromberg J, et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. PMID 32795414 DOI: 10.1016/J.Cell.2020.07.009 |
0.336 |
|
| 2020 |
Ridouani F, Solomon SB, Bryce Y, Bromberg JF, Sofocleous CT, Deipolyi AR. Predictors of Progression-Free Survival and Local Tumor Control after Percutaneous Thermal Ablation of Oligometastatic Breast Cancer: Retrospective Study. Journal of Vascular and Interventional Radiology : Jvir. 31: 1201-1209. PMID 32698956 DOI: 10.1016/J.Jvir.2020.02.016 |
0.399 |
|
| 2020 |
Wang DG, Barrios DM, Blinder VS, Bromberg JF, Drullinsky PR, Funt SA, Jhaveri KL, Lake DE, Lyons T, Modi S, Razavi P, Sidel M, Traina TA, Vahdat LT, Lacouture ME. Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer. Breast Cancer Research and Treatment. PMID 32613539 DOI: 10.1007/S10549-020-05726-Y |
0.374 |
|
| 2020 |
Ross DS, Liu B, Schram AM, Razavi P, Lagana SM, Zhang Y, Scaltriti M, Bromberg JF, Ladanyi M, Hyman DM, Drilon A, Zehir A, Benayed R, Chandarlapaty S, Hechtman JF. Enrichment of Kinase Fusions in ESR1 Wild Type, Metastatic Breast Cancer Revealed by a Systematic Analysis of 4,854 Patients. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 32348852 DOI: 10.1016/J.Annonc.2020.04.008 |
0.412 |
|
| 2020 |
S DMBM, Wang DG, Blinder VS, Bromberg J, Drullinsky P, Funt SA, Jhaveri KL, Lake D, Lyons T, Modi S, Razavi P, Sidel M, Traina TA, Vahdat LT, Lacouture ME. Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients. Journal of Clinical Oncology. 38: 1063-1063. DOI: 10.1200/Jco.2020.38.15_Suppl.1063 |
0.379 |
|
| 2020 |
Gucalp A, Boyle LA, Alano T, Arumov A, Gounder MM, Patil S, Feigin K, Edelweiss M, D'Andrea G, Bromberg J, Goldfarb SB, Ligresti L, Wong ST, Traina TA. Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer. Journal of Clinical Oncology. 38: 1017-1017. DOI: 10.1200/Jco.2020.38.15_Suppl.1017 |
0.35 |
|
| 2020 |
Ridouani F, Solomon S, Bryce Y, Bromberg J, Sofocleous C, England R, Deipolyi A. 3:27 PM Abstract No. 35 Factors affecting outcomes of ablation for oligometastatic breast cancer: the importance of ablation margins Journal of Vascular and Interventional Radiology. 31. DOI: 10.1016/J.Jvir.2019.12.057 |
0.358 |
|
| 2019 |
Kulkarni S, Yarmohammadi H, Sofocleous C, Aguirre AG, Bryce Y, Boas F, Bromberg J, Wong S, Traina T, Deipolyi A. 03:18 PM Abstract No. 433 Hepatotoxicity after radioembolization for liver metastases due to breast cancer in the setting of systemic therapy Journal of Vascular and Interventional Radiology. 30. DOI: 10.1016/J.Jvir.2018.12.513 |
0.345 |
|
| 2018 |
Deipolyi AR, Riedl CC, Bromberg J, Chandarlapaty S, Klebanoff CA, Sofocleous CT, Yarmohammadi H, Brody LA, Boas FE, Ziv E. Association of PI3K Pathway Mutations with Early Positron-Emission Tomography/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single-Center Retrospective Pilot Study. Journal of Vascular and Interventional Radiology : Jvir. PMID 30078647 DOI: 10.1016/J.Jvir.2018.04.018 |
0.348 |
|
| 2018 |
Morris PG, Rota S, Cadoo K, Zamora S, Patil S, D'Andrea G, Gilewski T, Bromberg J, Dang C, Dickler M, Modi S, Seidman AD, Sklarin N, Norton L, Hudis CA, et al. Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer. Clinical Breast Cancer. PMID 29680193 DOI: 10.1016/J.Clbc.2018.03.010 |
0.408 |
|
| 2018 |
Deipolyi AR, Bromberg JF, Erinjeri JP, Solomon SB, Brody LA, Riedl CC. Abscopal Effect after Radioembolization for Metastatic Breast Cancer in the Setting of Immunotherapy. Journal of Vascular and Interventional Radiology : Jvir. 29: 432-433. PMID 29455880 DOI: 10.1016/J.Jvir.2017.10.007 |
0.389 |
|
| 2018 |
Dunphy MPS, Harding JJ, Venneti S, Zhang H, Burnazi EM, Bromberg J, Omuro AM, Hsieh JJ, Mellinghoff IK, Staton K, Pressl C, Beattie BJ, Zanzonico PB, Gerecitano JF, Kelsen DP, et al. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R )-4-Fluoroglutamine. Radiology. 162610. PMID 29388903 DOI: 10.1148/Radiol.2017162610 |
0.334 |
|
| 2018 |
Lyons T, Gucalp A, Arumov A, Patil S, Edelweiss M, Gorsky M, Troso-Sandoval TA, Bromberg J, Sanford RA, Iyengar NM, Modi S, Gupta R, Traina TA. Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer. Journal of Clinical Oncology. 36: 531-531. DOI: 10.1200/Jco.2018.36.15_Suppl.531 |
0.326 |
|
| 2018 |
Deipolyi A, Riedl C, Bromberg J, Klebanoff C, Boas F, Yarmohammadi H, Brody L, Sofocleous C, Bryce Y, Chandarlapaty S, Ziv E. 3:27 PM Abstract No. 264 PI3K pathway mutations predict response on PET/CT after radioembolization as salvage therapy for heavily pretreated patients with breast cancer liver metastases Journal of Vascular and Interventional Radiology. 29. DOI: 10.1016/J.Jvir.2018.01.295 |
0.349 |
|
| 2017 |
Geter PA, Ernlund AW, Bakogianni S, Alard A, Arju R, Giashuddin S, Gadi A, Bromberg J, Schneider RJ. Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming. Genes & Development. 31: 2235-2249. PMID 29269484 DOI: 10.1101/Gad.305631.117 |
0.415 |
|
| 2017 |
Sonnenblick A, Salgado R, Brohée S, Zahavi T, Peretz T, Van den Eynden G, Rouas G, Salmon A, Francis PA, Di Leo A, Crown JPA, Viale G, Daly L, Javdan B, Fujisawa S, ... ... Bromberg JF, et al. p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial. International Journal of Oncology. PMID 29207087 DOI: 10.3892/Ijo.2017.4212 |
0.387 |
|
| 2017 |
Sansone P, Savini C, Kurelac I, Chang Q, Amato LB, Strillacci A, Stepanova A, Iommarini L, Mastroleo C, Daly L, Galkin A, Thakur BK, Soplop N, Uryu K, Hoshinob A, ... ... Bromberg J, et al. Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 114: E9066-E9075. PMID 29073103 DOI: 10.1073/Pnas.1704862114 |
0.404 |
|
| 2017 |
Huang Y, Rajappa P, Hu W, Hoffman C, Cisse B, Kim JH, Gorge E, Yanowitch R, Cope W, Vartanian E, Xu R, Zhang T, Pisapia D, Xiang J, Huse J, ... ... Bromberg J, et al. A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma. The Journal of Clinical Investigation. PMID 28394259 DOI: 10.1172/Jci86443 |
0.407 |
|
| 2017 |
Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, Bissell MJ, Cox TR, Giaccia AJ, Erler JT, Hiratsuka S, et al. Pre-metastatic niches: organ-specific homes for metastases. Nature Reviews. Cancer. PMID 28303905 DOI: 10.1038/Nrc.2017.6 |
0.341 |
|
| 2017 |
Sansone P, Berishaj M, Rajasekhar VK, Ceccarelli C, Chang Q, Strillacci A, Savini C, Shapiro L, Bowman R, Mastroleo C, De Carolis S, Daly L, Benito-Martin A, Perna F, Fabbri N, ... ... Bromberg J, et al. Evolution of cancer stem-like cells in endocrine-resistant metastatic breast cancers is mediated by stromal microvesicles. Cancer Research. PMID 28202520 DOI: 10.1158/0008-5472.Can-16-2129 |
0.437 |
|
| 2017 |
Tonorezos ES, Barnea D, Abou-Alfa GK, Bromberg J, D'Angelica M, Sklar CA, Shia J, Oeffinger KC. Hepatocellular adenoma among adult survivors of childhood and young adult cancer Pediatric Blood & Cancer. 64. PMID 27781382 DOI: 10.1002/Pbc.26294 |
0.302 |
|
| 2017 |
DeMichele A, Clark A, Holmes R, Volpe M, Medrano C, Troxel A, Fox K, Domchek S, Matro J, Bradbury A, Shih N, Feldman M, Hexner E, Bromberg J. Abstract P2-08-03: Targeting inflammatory pathways: A phase 2 trial of the JAK-inhibitor ruxolitinib in combination with exemestane for aromatase inhibitor-resistant, estrogen receptor-positive breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P2-08-03 |
0.384 |
|
| 2017 |
Sonnenblick A, Salgado R, Peretz T, Francis P, Crown JPA, Azambuja ED, Lieveke A, Piccart M, Bromberg JF, Sotiriou C. 25OpSTAT3 in luminal breast cancer. Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial Annals of Oncology. 28. DOI: 10.1093/Annonc/Mdx138.002 |
0.336 |
|
| 2016 |
Rajappa P, Cobb WS, Vartanian E, Huang Y, Daly L, Hoffman C, Zhang J, Shen B, Yanowitch R, Garg K, Cisse B, Haddock S, Huse JT, Pisapia DJ, Chan TA, ... ... Bromberg J, et al. Malignant astrocytic tumor progression potentiated by JAK-mediated recruitment of myeloid cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28039266 DOI: 10.1158/1078-0432.Ccr-16-1508 |
0.363 |
|
| 2016 |
Yu HA, Perez L, Chang Q, Gao SP, Kris MG, Riely GJ, Bromberg J. A phase 1/2 trial of ruxolitinib and erlotinib in patients with EGFR-mutant lung adenocarcinomas with acquired resistance to erlotinib. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 27613527 DOI: 10.1016/J.Jtho.2016.08.140 |
0.322 |
|
| 2016 |
Gao SP, Chang Q, Mao N, Daly LA, Vogel R, Chan T, Liu SH, Bournazou E, Schori E, Zhang H, Red Brewer M, Pao W, Morris L, Ladanyi M, Arcila M, ... ... Bromberg JF, et al. JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors. Science Signaling. 9: ra33. PMID 27025877 DOI: 10.1126/Scisignal.Aac8460 |
0.611 |
|
| 2016 |
Sansone P, Ceccarelli C, Berishaj M, Chang Q, Rajasekhar VK, Perna F, Bowman RL, Vidone M, Daly L, Nnoli J, Santini D, Taffurelli M, Shih NN, Feldman M, Mao JJ, ... ... Bromberg J, et al. Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer. Nature Communications. 7: 10442. PMID 26858125 DOI: 10.1038/Ncomms10442 |
0.403 |
|
| 2016 |
Sansone P, Berishaj M, Chang Q, Strillacci A, Giacco F, Bromberg J. Abstract B05: Inhibition of ER/Stat3 signaling pathways drive the evolution of ER+ metastatic breast cancer through the generation of ER-independent OXPHOShi self-renewing cells Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-B05 |
0.469 |
|
| 2016 |
Sansone P, Claudio C, Berishaj M, Chang Q, Vinagolu R, Perna F, Bowman R, Vidone M, Daly L, Nnoli J, Santini D, Mario T, Shih N, Feldman M, Mao JJ, ... ... Bromberg JF, et al. Abstract LB-236: Self-renewal of CD133hi cells by IL6/Notch3 signaling regulates endocrine resistance in metastatic breast cancers Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-236 |
0.439 |
|
| 2015 |
Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, ... ... Bromberg J, et al. Tumour exosome integrins determine organotropic metastasis. Nature. PMID 26524530 DOI: 10.1038/Nature15756 |
0.34 |
|
| 2015 |
Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, García-Santos G, Williams C, ... ... Bromberg J, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology. 17: 816-26. PMID 25985394 DOI: 10.1038/Ncb3169 |
0.312 |
|
| 2015 |
Papaspyridonos M, Matei I, Huang Y, do Rosario Andre M, Brazier-Mitouart H, Waite JC, Chan AS, Kalter J, Ramos I, Wu Q, Williams C, Wolchok JD, Chapman PB, Peinado H, Anandasabapathy N, ... ... Bromberg J, et al. Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation. Nature Communications. 6: 6840. PMID 25924227 DOI: 10.1038/Ncomms7840 |
0.327 |
|
| 2015 |
Kleppe M, Kwak M, Koppikar P, Riester M, Keller M, Bastian L, Hricik T, Bhagwat N, McKenney AS, Papalexi E, Abdel-Wahab O, Rampal R, Marubayashi S, Chen JJ, Romanet V, ... ... Bromberg J, et al. JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response. Cancer Discovery. 5: 316-31. PMID 25572172 DOI: 10.1158/2159-8290.Cd-14-0736 |
0.382 |
|
| 2015 |
Walsh LA, Roy DM, Reyngold M, Giri D, Snyder A, Turcan S, Badwe CR, Lyman J, Bromberg J, King TA, Chan TA. RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch. Oncogene. 34: 2189-203. PMID 24931164 DOI: 10.1038/Onc.2014.175 |
0.484 |
|
| 2015 |
DeMichele AM, Colameco CB, Kalota A, Troxel AB, Holmes R, Cimildoro R, Zafman K, Fox KR, Domchek SM, Gogineni K, Bradbury AR, Matro JM, Shih N, Feldman MD, Clark AS, ... ... Bromberg JF, et al. Abstract CT114: A phase II trial of exemestane and ruxolitinib for aI-resistant ER+ breast cancer: Interim safety, efficacy, and biomarker analysis Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Ct114 |
0.424 |
|
| 2014 |
Shike M, Doane AS, Russo L, Cabal R, Reis-Filho JS, Gerald W, Cody H, Khanin R, Bromberg J, Norton L. The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study. Journal of the National Cancer Institute. 106. PMID 25190728 DOI: 10.1093/Jnci/Dju189 |
0.375 |
|
| 2014 |
Osmanbeyoglu HU, Pelossof R, Bromberg JF, Leslie CS. Linking signaling pathways to transcriptional programs in breast cancer. Genome Research. 24: 1869-80. PMID 25183703 DOI: 10.1101/Gr.173039.114 |
0.457 |
|
| 2014 |
Gholami S, Chen CH, Gao S, Lou E, Fujisawa S, Carson J, Nnoli JE, Chou TC, Bromberg J, Fong Y. Role of MAPK in oncolytic herpes viral therapy in triple-negative breast cancer. Cancer Gene Therapy. 21: 283-9. PMID 24924199 DOI: 10.1038/Cgt.2014.28 |
0.352 |
|
| 2014 |
Ortiz B, Fabius AW, Wu WH, Pedraza A, Brennan CW, Schultz N, Pitter KL, Bromberg JF, Huse JT, Holland EC, Chan TA. Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis. Proceedings of the National Academy of Sciences of the United States of America. 111: 8149-54. PMID 24843164 DOI: 10.1073/Pnas.1401952111 |
0.368 |
|
| 2014 |
Cuzzone DA, Weitman ES, Albano NJ, Ghanta S, Savetsky IL, Gardenier JC, Joseph WJ, Torrisi JS, Bromberg JF, Olszewski WL, Rockson SG, Mehrara BJ. IL-6 regulates adipose deposition and homeostasis in lymphedema American Journal of Physiology - Heart and Circulatory Physiology. 306: H1426-H1434. PMID 24633552 DOI: 10.1152/Ajpheart.01019.2013 |
0.312 |
|
| 2014 |
Chang Q, Daly L, Bromberg J. The IL-6 feed-forward loop: a driver of tumorigenesis. Seminars in Immunology. 26: 48-53. PMID 24613573 DOI: 10.1016/J.Smim.2014.01.007 |
0.395 |
|
| 2014 |
Huang Y, Hoffman C, Rajappa P, Kim JH, Hu W, Huse J, Tang Z, Li X, Weksler B, Bromberg J, Lyden DC, Greenfield JP. Oligodendrocyte progenitor cells promote neovascularization in glioma by disrupting the blood-brain barrier. Cancer Research. 74: 1011-21. PMID 24371228 DOI: 10.1158/0008-5472.Can-13-1072 |
0.354 |
|
| 2014 |
Cadoo KA, Shah PD, Charen AS, Bromberg J, Comen EA, D'Andrea G, Dang CT, Gilewski T, Gucalp A, Lake D, Seidman AD, Theodoulou M, Traina TA, Hudis CA, Norton L, et al. A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer. Journal of Clinical Oncology. 32: 6601-6601. DOI: 10.1200/Jco.2014.32.15_Suppl.6601 |
0.327 |
|
| 2014 |
Demichele AM, Donelson M, Komrokian S, Colameco C, Chen J, Chen L, Gray R, Nnoli J, Vaughan W, Anderson K, Bromberg J. Abstract 4719: Associations between IL-6 genotype and IL-6-related tumor alterations in ER+ breast cancer: results from ECOG2190/Int0121 Cancer Research. 74: 4719-4719. DOI: 10.1158/1538-7445.Am2014-4719 |
0.43 |
|
| 2014 |
Rajappa P, Huang Y, Vartanian E, Pisapia D, Lyden D, Bromberg J, Greenfield J. ME-17JAK 1/2 INHIBITION FOLLOWING BONE MARROW TRANSPLANTATION MITIGATES Cd11b + /GR1+ MEDIATED LOW-GRADE GLIOMA NEOANGIOGENESIS Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou261.16 |
0.33 |
|
| 2014 |
Huang Y, Rajappa P, Bromberg J, Lyden D, Greenfield J. Ai-12Id2/Kdr Drives Formation Of Pro-Malignant Myeloid Derived Suppressor Cells In Glioma Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou238.12 |
0.371 |
|
| 2013 |
Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X, Cotari J, Alpaugh ML, de Stanchina E, Manova K, Li M, ... ... Bromberg J, et al. The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia (New York, N.Y.). 15: 848-62. PMID 23814496 DOI: 10.1593/Neo.13706 |
0.666 |
|
| 2013 |
Avraham T, Zampell JC, Yan A, Elhadad S, Weitman ES, Rockson SG, Bromberg J, Mehrara BJ. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema The Faseb Journal. 27: 1114-1126. PMID 23193171 DOI: 10.1096/Fj.12-222695 |
0.331 |
|
| 2013 |
Sansone P, Bonafe M, Ceccarelli C, Berishaj M, Bromberg J. Abstract B089: The suppression of ERa activity promotes the mitochondrial deficient CD133hi/Notch3hi/ERalowcancer stem cell phenotype via autocrine IL6 in luminal breast cancer Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-B089 |
0.5 |
|
| 2013 |
Lyden D, Peinado-Selgas H, Nitadori A, Shen T, Aleckovic M, Kang Y, Bromberg J. Abstract BS03-1: Tumor-derived exosomes promote pre-metastatic niche formation and organotropism Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-Bs03-1 |
0.425 |
|
| 2013 |
Gholami S, Chen C, Lou E, Marano D, Belin LJ, Bromberg J, Chou T, Fong Y. Oncolytic herpes simplex virus shows synergistic effects with rapamycin against triple-negative breast cancer Journal of the American College of Surgeons. 217. DOI: 10.1016/J.Jamcollsurg.2013.07.325 |
0.367 |
|
| 2012 |
Couto JP, Almeida A, Daly L, Sobrinho-Simões M, Bromberg JF, Soares P. AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines. Plos One. 7: e46869. PMID 23056499 DOI: 10.1371/Journal.Pone.0046869 |
0.443 |
|
| 2012 |
Couto JP, Daly L, Almeida A, Knauf JA, Fagin JA, Sobrinho-Simões M, Lima J, Máximo V, Soares P, Lyden D, Bromberg JF. STAT3 negatively regulates thyroid tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America. 109: E2361-70. PMID 22891351 DOI: 10.1073/Pnas.1201232109 |
0.463 |
|
| 2012 |
Koppikar P, Bromberg J. STATe-of-the-Art Approach: Using Oligonucleotide Decoys to Target the “Undruggable” Cancer Discovery. 2: 670-672. PMID 22886660 DOI: 10.1158/2159-8290.Cd-12-0310 |
0.364 |
|
| 2012 |
Peinado H, Ale?kovi? M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, ... ... Bromberg J, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine. 18: 883-91. PMID 22635005 DOI: 10.1038/Nm.2753 |
0.352 |
|
| 2012 |
Sansone P, Bromberg J. Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies Journal of Clinical Oncology. 30: 1005-1014. PMID 22355058 DOI: 10.1200/Jco.2010.31.8907 |
0.442 |
|
| 2012 |
Sansone P, Ceccarelli C, Storci G, Berishaj M, Cricca M, Chang Q, Santini D, Bonafe M, Bromberg J. Abstract 1514: The Warburg effect in stromal cells drives breast cancer cell plasticity via interleukin 6 Cancer Research. 72: 1514-1514. DOI: 10.1158/1538-7445.Am2012-1514 |
0.497 |
|
| 2012 |
Proescholdt MA, Merrill MJ, Stoerr E, Lohmeier A, Brawanski A, Sim H, Hu B, Pineda CA, Yoon S, Viapiano MS, Rajappa P, Cobb WS, Huang Y, Lyden DC, Bromberg J, et al. LAB-ANGIOGENESIS AND INVASION Neuro-Oncology. 14: vi1-vi6. DOI: 10.1093/Neuonc/Nos219 |
0.306 |
|
| 2011 |
Azare J, Doane A, Leslie K, Chang Q, Berishaj M, Nnoli J, Mark K, Al-Ahmadie H, Gerald W, Hassimi M, Viale A, Stracke M, Lyden D, Bromberg J. Stat3 mediates expression of autotaxin in breast cancer. Plos One. 6: e27851. PMID 22140473 DOI: 10.1371/Journal.Pone.0027851 |
0.502 |
|
| 2011 |
Zammarchi F, de Stanchina E, Bournazou E, Supakorndej T, Martires K, Riedel E, Corben AD, Bromberg JF, Cartegni L. Antitumorigenic potential of STAT3 alternative splicing modulation. Proceedings of the National Academy of Sciences of the United States of America. 108: 17779-84. PMID 22006329 DOI: 10.1073/Pnas.1108482108 |
0.421 |
|
| 2011 |
Sansone P, Bromberg J. Environment, inflammation, and cancer. Current Opinion in Genetics & Development. 21: 80-85. PMID 21144738 DOI: 10.1016/J.Gde.2010.11.001 |
0.399 |
|
| 2011 |
Shapiro LQ, Sansone P, Granitto S, Lyden D, Bromberg J. Abstract 546: Effects of high-dose radiotherapy on the bone marrow microenvironment in the 4T1 model of breast cancer Cancer Research. 71: 546-546. DOI: 10.1158/1538-7445.Am2011-546 |
0.382 |
|
| 2011 |
Gao SP, Mao N, Schori E, Liu S, Daly L, Barlas A, Gueorguiev VD, Zhao H, Qiu J, Hefter B, Regales L, Chmielecki J, Pao W, Bromberg JF. Abstract 4689: Inhibition of IL-6/Jak/Stat3 signaling: a novel and potent targeting therapy for lung cancer Cancer Research. 71: 4689-4689. DOI: 10.1158/1538-7445.Am2011-4689 |
0.471 |
|
| 2011 |
Jamshidi F, Zhang L, Heguy A, Doane A, Gerald W, Bromberg J, Hudis C. Abstract 2879: Mechanisms of integration for androgen receptor and phosphatidylinositol 3-kinase signaling in estrogen receptor negative class A breast cancer Cancer Research. 71: 2879-2879. DOI: 10.1158/1538-7445.Am2011-2879 |
0.462 |
|
| 2011 |
Silva J, Soares P, Knauf J, Fagin J, Sobrinho-Simoes M, Ghossein R, Bromberg JF. Abstract 1075: STAT3 signaling in thyroid cancer Cancer Research. 71: 1075-1075. DOI: 10.1158/1538-7445.Am2011-1075 |
0.482 |
|
| 2011 |
Chang Q, Sansone P, Zhang M, Bournazou E, Andre R, Peinado H, Alpaugh M, Schneider R, Yan C, Lyden D, Bromberg J. Targeting the IL-6/Jak Pathway in Breast Cancer The Breast. 20. DOI: 10.1016/J.Breast.2011.08.009 |
0.425 |
|
| 2010 |
Leslie K, Gao SP, Berishaj M, Podsypanina K, Ho H, Ivashkiv L, Bromberg J. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation. Breast Cancer Research : Bcr. 12: R80. PMID 20929542 DOI: 10.1186/Bcr2725 |
0.434 |
|
| 2010 |
Koppikar P, Abdel-Wahab O, Hedvat C, Marubayashi S, Patel J, Goel A, Kucine N, Gardner JR, Combs AP, Vaddi K, Haley PJ, Burn TC, Rupar M, Bromberg JF, Heaney ML, et al. Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis Blood. 115: 2919-2927. PMID 20154217 DOI: 10.1182/Blood-2009-04-218842 |
0.353 |
|
| 2010 |
Silva J, Soares P, Trovisco V, Knauf J, Fagin J, Bromberg J. Abstract 3138: Stat3 signaling in thyroid cancer Cancer Research. 70: 3138-3138. DOI: 10.1158/1538-7445.Am10-3138 |
0.476 |
|
| 2009 |
Bromberg J, Wang TC. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell. 15: 79-80. PMID 19185839 DOI: 10.1016/J.Ccr.2009.01.009 |
0.389 |
|
| 2008 |
Dickler MN, Rugo HS, Eberle CA, Brogi E, Caravelli JF, Panageas KS, Boyd J, Yeh B, Lake DE, Dang CT, Gilewski TA, Bromberg JF, Seidman AD, D'Andrea GM, Moasser MM, et al. A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7878-83. PMID 19047117 DOI: 10.1158/1078-0432.Ccr-08-0141 |
0.394 |
|
| 2008 |
Bhandarkar SS, Bromberg J, Carrillo C, Selvakumar P, Sharma RK, Perry BN, Govindarajan B, Fried L, Sohn A, Reddy K, Arbiser JL. Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo. Clinical Cancer Research. 14: 5743-5748. PMID 18794083 DOI: 10.1158/1078-0432.Ccr-08-0405 |
0.393 |
|
| 2008 |
de la Iglesia N, Konopka G, Lim KL, Nutt CL, Bromberg JF, Frank DA, Mischel PS, Louis DN, Bonni A. Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 5870-8. PMID 18524891 DOI: 10.1523/Jneurosci.5385-07.2008 |
0.456 |
|
| 2007 |
Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, Travis WD, Bornmann W, Veach D, Clarkson B, Bromberg JF. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. The Journal of Clinical Investigation. 117: 3846-56. PMID 18060032 DOI: 10.1172/Jci31871 |
0.41 |
|
| 2007 |
Berishaj M, Gao SP, Ahmed S, Leslie K, Al-Ahmadie H, Gerald WL, Bornmann W, Bromberg JF. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer Breast Cancer Research. 9. PMID 17531096 DOI: 10.1186/Bcr1680 |
0.478 |
|
| 2007 |
Azare J, Leslie K, Al-Ahmadie H, Gerald W, Weinreb PH, Violette SM, Bromberg J. Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6. Molecular and Cellular Biology. 27: 4444-53. PMID 17438134 DOI: 10.1128/Mcb.02404-06 |
0.351 |
|
| 2006 |
Pedranzini L, Dechow T, Berishaj M, Comenzo R, Zhou P, Azare J, Bornmann W, Bromberg J. Pyridone 6, a Pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells Cancer Research. 66: 9714-9721. PMID 17018630 DOI: 10.1158/0008-5472.Can-05-4280 |
0.414 |
|
| 2006 |
Leslie K, Lang C, Devgan G, Azare J, Berishaj M, Gerald W, Kim YB, Paz K, Darnell JE, Albanese C, Sakamaki T, Pestell R, Bromberg J. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Research. 66: 2544-52. PMID 16510571 DOI: 10.1158/0008-5472.Can-05-2203 |
0.386 |
|
| 2004 |
Pedranzini L, Leitch A, Bromberg J. Stat3 is required for the development of skin cancer. Journal of Clinical Investigation. 114: 619-622. PMID 15343379 DOI: 10.1172/Jci22800 |
0.465 |
|
| 2004 |
Dechow TN, Pedranzini L, Leitch A, Leslie K, Gerald WL, Linkov I, Bromberg JF. Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C. Proceedings of the National Academy of Sciences of the United States of America. 101: 10602-7. PMID 15249664 DOI: 10.1073/Pnas.0404100101 |
0.42 |
|
| 2003 |
Zhang J, Yang J, Roy SK, Tininini S, Hu J, Bromberg JF, Poli V, Stark GR, Kalvakolanu DV. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3. Proceedings of the National Academy of Sciences of the United States of America. 100: 9342-7. PMID 12867595 DOI: 10.1073/Pnas.1633516100 |
0.371 |
|
| 2003 |
Albanese C, Wu K, D'Amico M, Jarrett C, Joyce D, Hughes J, Hulit J, Sakamaki T, Fu M, Ben-Ze'ev A, Bromberg JF, Lamberti C, Verma U, Gaynor RB, Byers SW, et al. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Molecular Biology of the Cell. 14: 585-99. PMID 12589056 DOI: 10.1091/Mbc.02-06-0101 |
0.328 |
|
| 2002 |
Tumang JR, Hsia CY, Tian W, Bromberg JF, Liou HC. IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2. Cellular Immunology. 217: 47-57. PMID 12426000 DOI: 10.1016/S0008-8749(02)00513-0 |
0.338 |
|
| 2002 |
Bromberg J. Stat proteins and oncogenesis. Journal of Clinical Investigation. 109: 1139-1142. PMID 11994401 DOI: 10.1172/Jci15617 |
0.429 |
|
| 2002 |
Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 21: 2000-8. PMID 11960372 DOI: 10.1038/Sj.Onc.1205260 |
0.407 |
|
| 2001 |
Bromberg J, Chen X. STAT proteins: signal tranducers and activators of transcription. Methods in Enzymology. 333: 138-151. PMID 11400331 DOI: 10.1016/S0076-6879(01)33052-5 |
0.309 |
|
| 2001 |
Bromberg JF. Activation Of Stat Proteins And Growth Control Bioessays. 23: 161-169. PMID 11169589 DOI: 10.1002/1521-1878(200102)23:2<161::Aid-Bies1023>3.0.Co;2-0 |
0.363 |
|
| 2001 |
Shen Y, Devgan G, Darnell JE, Bromberg JF. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proceedings of the National Academy of Sciences of the United States of America. 98: 1543-1548. DOI: 10.1073/Pnas.98.4.1543 |
0.38 |
|
| 2000 |
Bromberg J. Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development. Breast Cancer Research. 2: 86-90. PMID 11250696 DOI: 10.1186/Bcr38 |
0.421 |
|
| 2000 |
Bromberg J, Darnell JE. The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 19: 2468-73. PMID 10851045 DOI: 10.1038/Sj.Onc.1203476 |
0.434 |
|
| 1999 |
Bromberg JF, Darnell JE. Potential roles of Stat1 and Stat3 in cellular transformation. Cold Spring Harbor Symposia On Quantitative Biology. 64: 425-8. PMID 11232317 DOI: 10.1101/Sqb.1999.64.425 |
0.305 |
|
| 1999 |
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE. Stat3 as an oncogene. Cell. 98: 295-303. PMID 10458605 DOI: 10.1016/S0092-8674(00)81959-5 |
0.393 |
|
| 1999 |
Besser D, Bromberg JF, Darnell JE, Hanafusa H. A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation. Molecular and Cellular Biology. 19: 1401-9. PMID 9891073 DOI: 10.1128/Mcb.19.2.1401 |
0.308 |
|
| 1998 |
Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JE. Stat3 activation is required for cellular transformation by v-src. Molecular and Cellular Biology. 18: 2553-8. PMID 9566875 DOI: 10.1128/Mcb.18.5.2553 |
0.322 |
|
| 1996 |
Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell JE. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proceedings of the National Academy of Sciences of the United States of America. 93: 7673-8. PMID 8755534 DOI: 10.1073/Pnas.93.15.7673 |
0.314 |
|
| 1993 |
Bromberg J, Scher HI. Incorporating tumor biology into therapy for prostate cancer. Current Opinion in Oncology. 5: 546-558. PMID 8494915 DOI: 10.1097/00001622-199305000-00017 |
0.332 |
|
| Show low-probability matches. |